Temozolomide (TMZ), the chemotherapy agent for GBM, is an alkylating agent that causes the methylation of DNA, resulting in anticancer effects5, and GBMs with methylated O6-methylguanine DNA methyltransferase (MGMT) promoters are more sensitive to TMZ5, 6. Here, MGMT is linked to glioblastoma.